quinoxalines has been researched along with Sepsis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (38.46) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Assreuy, J; Barp, CG; Benedet, PO | 1 |
| Nie, Z; Wang, J; Xia, X; Zhang, S; Zhang, Y; Zhao, Y | 1 |
| Fan, TT; Feng, XY; Gao, F; Liu, Q; Yang, YZ | 1 |
| Blackwell, TS; Han, W; Li, H; Polosukhin, V; Segal, BH; Xie, CM; Yull, FE | 1 |
| Albertine, KH; Cai, L; Cho, J; Dai, Z; Huang, X; Malik, AB; Schraufnagel, DE; Sun, K; Zhao, YY | 1 |
| Assreuy, J; Barja-Fidalgo, C; Fernandes, D; Heckert, BT; Lobo, AR; Nardi, GM; Pacheco, LK; Sordi, R; Villela, CG | 1 |
| Aguila, FA; Basso, PJ; Oliveira-Pelegrin, GR; Rocha, MJ | 1 |
| Ahanger, AA; Choudhury, S; Kandasamy, K; Mishra, SK; More, AS; Parida, S; Prawez, S; Singh, TU | 1 |
| Carlin, AM; Kerkar, S; Steffes, CP; Tyburski, JG; Williams, M; Wilson, RF | 1 |
| Atkinson, J; Giummelly, P; Mansard, A; Wang, C | 1 |
| Bose, D; Bose, R; Cheng, ZQ; Duke, K; Jacobs, H; Light, RB; Mink, SN; Roberts, DE | 1 |
| Bose, R; Cheng, ZQ; Jacobs, H; Kasian, K; Light, RB; Mink, SN; Santos Martinez, LE | 1 |
| Antipov, AV | 1 |
13 other study(ies) available for quinoxalines and Sepsis
| Article | Year |
|---|---|
Perivascular adipose tissue phenotype and sepsis vascular dysfunction: Differential contribution of NO, ROS and beta 3-adrenergic receptor.
Topics: Acetophenones; Adipose Tissue; Adrenergic beta-3 Receptor Agonists; Animals; Aorta; Cyclic N-Oxides; Female; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Oxadiazoles; Phenotype; Quinoxalines; Rats; Reactive Oxygen Species; Receptors, Adrenergic, beta-3; Sepsis; Spin Labels; Vasoconstriction | 2020 |
JNK selective inhibitor, IQ-1S, protects the mice against lipopolysaccharides-induced sepsis.
Topics: Animals; Cells, Cultured; Dose-Response Relationship, Drug; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Molecular Structure; Oximes; Protective Agents; Protein Kinase Inhibitors; Quinoxalines; Sepsis; Signal Transduction; Structure-Activity Relationship | 2021 |
Downregulation of PI3K-γ in a mouse model of sepsis-induced myocardial dysfunction.
Topics: Animals; Cardiomyopathies; Chromones; Class II Phosphatidylinositol 3-Kinases; Cytokines; Disease Models, Animal; Down-Regulation; Interleukin-6; Lipopolysaccharides; Mice; Morpholines; Myocardium; Quinoxalines; Sepsis; Signal Transduction; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2017 |
NF-κB inhibition after cecal ligation and puncture reduces sepsis-associated lung injury without altering bacterial host defense.
Topics: Acute Lung Injury; Animals; Bacterial Infections; Cells, Cultured; I-kappa B Kinase; Imidazoles; Ligation; Macrophages; Mice; Neutrophils; NF-kappa B; Phagocytosis; Quinoxalines; Sepsis | 2013 |
Endothelial p110γPI3K Mediates Endothelial Regeneration and Vascular Repair After Inflammatory Vascular Injury.
Topics: Androstadienes; Animals; Capillary Leak Syndrome; Capillary Permeability; Cells, Cultured; Class Ib Phosphatidylinositol 3-Kinase; Endothelium, Vascular; Enzyme Activation; Enzyme Induction; Forkhead Box Protein M1; Forkhead Transcription Factors; Furans; Humans; Lung; Mice; Mice, Knockout; Microvessels; Neutrophils; Phosphoinositide-3 Kinase Inhibitors; Protein Isoforms; Pulmonary Edema; Pyridines; Pyrimidines; Quinoxalines; Recombinant Fusion Proteins; Regeneration; Respiratory Distress Syndrome; Sepsis; Signal Transduction; Thiazolidinediones; Transfection; Wortmannin | 2016 |
Late, but not early, inhibition of soluble guanylate cyclase decreases mortality in a rat sepsis model.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Cecum; Cyclic GMP; Disease Models, Animal; Drug Administration Schedule; Enzyme Inhibitors; Female; Guanylate Cyclase; Methylene Blue; Mortality; Oxadiazoles; Quinoxalines; Rats; Rats, Wistar; RNA, Messenger; Sepsis; Vasoconstriction | 2009 |
Role of central NO-cGMP pathway in vasopressin and oxytocin gene expression during sepsis.
Topics: Animals; Arginine Vasopressin; Cyclic GMP; Enzyme Inhibitors; Gene Expression Regulation; Male; Nitric Oxide; Oxadiazoles; Oxytocin; Paraventricular Hypothalamic Nucleus; Quinoxalines; Rats; Rats, Wistar; Sepsis; Signal Transduction; Supraoptic Nucleus | 2010 |
Atorvastatin prevents vascular hyporeactivity to norepinephrine in sepsis: role of nitric oxide and α₁-adrenoceptor mRNA expression.
Topics: Animals; Atorvastatin; Enzyme Inhibitors; Guanylate Cyclase; Heptanoic Acids; Mice; Nitric Oxide; Norepinephrine; Oxadiazoles; Polymerase Chain Reaction; Pyrroles; Quinoxalines; Receptors, Adrenergic, alpha-1; RNA, Messenger; Sepsis; Vasoconstrictor Agents | 2011 |
The roles of cyclic adenosine monophosphate- and cyclic guanosine monophosphate-dependent protein kinase pathways in hydrogen peroxide-induced contractility of microvascular lung pericytes.
Topics: Adenine; Adenylyl Cyclase Inhibitors; Analysis of Variance; Animals; Cell Survival; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Hydrogen Peroxide; Isoquinolines; Lung; Male; Muscle Contraction; Oxadiazoles; Pericytes; Quinoxalines; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Sepsis; Sulfonamides | 2003 |
Decreased aortic smooth muscle contraction in a rat model of multibacterial sepsis.
Topics: Animals; Aorta; Disease Models, Animal; Endothelial Cells; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxadiazoles; Quinoxalines; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Sepsis; Soluble Guanylyl Cyclase | 2004 |
Lysozyme binding to endocardial endothelium mediates myocardial depression by the nitric oxide guanosine 3',5' monophosphate pathway in sepsis.
Topics: Animals; Cell Membrane; Cyclic GMP; Dogs; Endocardium; Endothelium; In Vitro Techniques; Muramidase; Myocardial Contraction; Myocardium; Nitric Oxide; omega-N-Methylarginine; Oxadiazoles; Quinoxalines; Sepsis | 2005 |
Lysozyme, a mediator of sepsis that produces vasodilation by hydrogen peroxide signaling in an arterial preparation.
Topics: Aminoquinolines; Animals; Carotid Artery, Internal; Catalase; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclooxygenase Inhibitors; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethanol; Free Radical Scavengers; Guanylate Cyclase; Humans; Hydrogen Peroxide; Hydroquinones; In Vitro Techniques; Indomethacin; Mannitol; Mesenteric Artery, Superior; Methylene Blue; Muramidase; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Oxadiazoles; Phenylephrine; Prostaglandins; Protein Kinase Inhibitors; Quinoxalines; Receptors, Cytoplasmic and Nuclear; Sepsis; Signal Transduction; Soluble Guanylyl Cyclase; Thionucleotides; Time Factors; Vasoconstrictor Agents; Vasodilation | 2008 |
[Chemotherapeutic effectiveness of mecillinam and dioxidine in an experiment using polyresistant Escherichia coli].
Topics: Amdinocillin; Ampicillin; Animals; Anti-Infective Agents; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Escherichia coli Infections; Mice; Plasmids; Quinoxalines; Sepsis | 1987 |